Contact
LinkedInBlogFacebookYouTube
Privacy Policy

Copyright © DEEPNOID Inc. All right reserved.

DEEP:NEURO

DEEP:NEURO detects saccular unruptured cerebral aneurysms in brain MRA images to support medical professionals in their reading.

Contact Us

Brain MRA-Based

Medical AI Solution

MFDS Approved

License No. 20-467

Innovative Medical Technology

NHI Non-Reimbursable Provisional Listing

DEEP:NEURO Case 1
Core Capabilities

3 Core Features

01

Precise Detection & Visualization

AI detects saccular unruptured cerebral aneurysms and marks them with bounding boxes. It identifies multiple aneurysms as well as small lesions under 2mm.

Precise Detection & Visualization
02

3D MIP Vascular Imaging

AI-analyzed cerebrovascular data is converted into MIP imaging. By showing vascular structures in 3D from multiple angles, the location and shape of lesions can be identified more accurately.

03

Analysis Report

Provides analysis results in report form, including the size, location, and rupture risk of cerebral aneurysms, supporting medical professionals' clinical decisions.

Analysis Report
Core Capabilities

Validated Clinical Performance

Sensitivity*: 91.11%
91.11%
Sensitivity*
Specificity*: 93.91%
93.91%
Specificity*

* Clinical Trial Site: Yonsei University Severance Hospital

Related Research

DEEP:NEURO's clinical performance has been validated through international journal papers and numerous conference presentations.

Innovative Medical Technology

Innovative Medical Technology Designation

An innovative medical technology that has completed evaluation by the National Evidence-based Healthcare Collaborating Agency (NECA) and the Ministry of Food and Drug Safety. Non-reimbursable claims are available in clinical settings.

• NHI Non-Reimbursable Provisional Listing

Are you considering adopting DEEP:NEURO?